Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.970
-0.350 (-8.10%)
At close: Oct 17, 2025, 4:00 PM EDT
3.950
-0.020 (-0.50%)
After-hours: Oct 17, 2025, 7:35 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $42.87 million as of October 17, 2025. Its market cap has increased by 7.35% in one year.
Market Cap
42.87M
Enterprise Value
27.12M
1-Year Change
7.35%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $42.87M, an increase of 41.36%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 42.87M | 24.62% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |